메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 23, Issue 36, 2005, Pages 9428-9429
Misleading statements in industry-sponsored meta-analysis of itraconazole [3]
Author keywords

[No Author keywords available]
Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; PLACEBO; VORICONAZOLE; ANTIFUNGAL AGENT;
EID: 33644830188     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.1608     Document Type: Letter
Times cited : (5)
References (7)
  • 1
    • 1542438612 scopus 로고    scopus 로고
    • Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: Evidence from a meta-analysis of 3,597 patients
    • Glasmacher A, Prentice A, Gorschluter M, et al: Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: Evidence from a meta-analysis of 3,597 patients. J Clin Oncol 21:4615-4626, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 4615-4626
    • Glasmacher, A.1    Prentice, A.2    Gorschluter, M.3
  • 2
    • 8244226648 scopus 로고    scopus 로고
    • Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia
    • Gøtzsche PC, Johansen HK: Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. BMJ 314:1238-1244, 1997
    • (1997) BMJ , vol.314 , pp. 1238-1244
    • Gøtzsche, P.C.1    Johansen, H.K.2
  • 3
    • 0036053594 scopus 로고    scopus 로고
    • Routine versus selective antifungal administration for control of fungal infections in patients with cancer
    • CD000026
    • Gøtzsche PC, Johansen HK: Routine versus selective antifungal administration for control of fungal infections in patients with cancer. Cochrane Database Syst Rev 2:CD000026, 2002
    • (2002) Cochrane Database Syst Rev , vol.2
    • Gøtzsche, P.C.1    Johansen, H.K.2
  • 4
    • 0037043655 scopus 로고    scopus 로고
    • Vonconazole versus amphotericin B for primary therapy of invasive aspergillosis
    • Herbrecht R, Denning DW, Patterson TF, et al: Vonconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415, 2002
    • (2002) N Engl J Med , vol.347 , pp. 408-415
    • Herbrecht, R.1    Denning, D.W.2    Patterson, T.F.3
  • 5
    • 0033544292 scopus 로고    scopus 로고
    • Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis
    • Johansen HK, Gøtzsche PC: Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA 282:1752-1759, 1999
    • (1999) JAMA , vol.282 , pp. 1752-1759
    • Johansen, H.K.1    Gøtzsche, P.C.2
  • 6
    • 0024929418 scopus 로고
    • Prophylaxis of fungal infections with itraconazole during remission-induction therapy
    • suppl 1
    • Prentice AG, Bradford GR: Prophylaxis of fungal infections with itraconazole during remission-induction therapy. Mycoses 32:96-102, 1989 (suppl 1)
    • (1989) Mycoses , vol.32 , pp. 96-102
    • Prentice, A.G.1    Bradford, G.R.2
  • 7
    • 0035795995 scopus 로고    scopus 로고
    • Congestive heart failure associated with itraconazole
    • Ahmad SR, Singer SJ, Leissa BG: Congestive heart failure associated with itraconazole. Lancet 357:1766-1767, 2001
    • (2001) Lancet , vol.357 , pp. 1766-1767
    • Ahmad, S.R.1    Singer, S.J.2    Leissa, B.G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.